Iradimed appoints Masimo founder Joe Kiani to board; Anthony Vuoto retires

IRADIMED CORP

Anthony Vuoto retired as director effective Aug 27, 2025; no disagreement with the company.
Joe Kiani, founder of Masimo and CEO of Willow Laboratories, appointed director effective Sep 2, 2025.
Kiani will serve on the Audit Committee and chair the Compensation Committee.
Board size remains at five directors after the transition.
Kiani receives standard non-employee director compensation as disclosed in the 2025 proxy.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.